Health
CEBINA reports positive findings on the potency of azelastine, a widely used anti-histamine, as anti-COVID-19 approach – PRNewswire
/PRNewswire/ — CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project,…

VIENNA, Sept. 17, 2020 /PRNewswire/ — CEBINA GmbH, an Austrian biotech company, today announces further positive results in its collaborative COVID-19 drug repurposing project, demonstrating that a common allergy nasal spray medication containing azelastine has potent efficacy against SARS-CoV-2 in a human 3D nasal tissue model.
Azelastine, a generic anti-histamine medication, has previously been identified as a potential anti-COVID-19 drug by CEBINA in collaboration with Professor Robert Konr…
-
Noosa News24 hours ago
ADF to introduce billion-dollar drone dome over Brisbane 2032
-
General21 hours ago
Queensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Noosa News20 hours ago
Family’s heartbreak after Trevor Doyle found dead in park in Logan
-
General20 hours ago
Two men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park